comparemela.com

Cardiff Oncology, Inc. (NASDAQ: CRDF) shares are trading higher Tuesday after-hours after the company announced clinical data in pancreatic cancer and small cell lung cancer, including single-agent activity

Related Keywords

Mark Erlander ,Cardiff Oncology Inc , ,Cardiff Oncology ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.